Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell and Indolent B-Cell Lymphomas

Conditions:   T-Cell Lymphoma;   Indolent B-Cell Lymphoma Interventions:   Drug: Duvelisib;   Procedure: Peripheral blood draw Sponsors:   Washington University School of Medicine;   Verastem, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials